The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation.

• 主要な著者: Nolan D Wood (著者), Danelle Smith (著者), Sally A Kinrade (著者), Mark T Sullivan (著者), Craig R Rayner (著者), David Wesche (著者), Kashyap Patel (著者), Karen Rowland-Yeo (著者)
• フォーマット: 図書
• 出版事項: Public Library of Science (PLoS), 2024-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Moxidectin is approved by the US Food and Drug Administration (US FDA) for the treatment of onchocerciasis (river-blindness) due to Onchocerca volvulus in patients aged 12 years and older. In onchocerciasis-endemic areas, mass drug administration (MDA) programs with ivermectin, with or without vecto...